My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 213

    1.

    Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects.

    Uribarri J, Stirban A, Sander D, Cai W, Negrean M, Buenting CE, Koschinsky T, Vlassara H.

    Diabetes Care. 2007 Oct;30(10):2579-82. Epub 2007 May 11.PMID: 17496238 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Serum level of advanced glycation end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population.

    Yamagishi S, Adachi H, Takeuchi M, Enomoto M, Furuki K, Matsui T, Nakamura K, Imaizumi T.

    Horm Metab Res. 2007 Nov;39(11):845-8.PMID: 17992643 [PubMed - indexed for MEDLINE]Related articles

    3.

    Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

    Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS.

    Diabetes Care. 2002 Jun;25(6):1055-9.PMID: 12032114 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

    Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D.

    Am J Clin Nutr. 2007 May;85(5):1236-43. Erratum in: Am J Clin Nutr. 2007 Oct;86(4):1256. PMID: 17490958 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.

    Schalkwijk CG, Ter Wee PM, Stehouwer CD.

    Ann N Y Acad Sci. 2005 Jun;1043:662-70.PMID: 16037290 [PubMed - indexed for MEDLINE]Related articles

    6.

    A novel advanced glycation index and its association with diabetes and microangiopathy.

    Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.

    Metabolism. 2005 Aug;54(8):1002-7.PMID: 16092048 [PubMed - indexed for MEDLINE]Related articles

    7.

    Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.

    Stam F, Schalkwijk CG, van Guldener C, ter Wee PM, Stehouwer CD.

    Nephrol Dial Transplant. 2006 Mar;21(3):677-82. Epub 2005 Dec 5.PMID: 16330467 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.

    Diabetes Care. 1998 May;21(5):841-8.PMID: 9589252 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications.

    Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, Nakagawa A, Kigoshi T, Ishibashi T, Nishio M, Uchida K.

    J Diabetes Complications. 2001 May-Jun;15(3):135-43.PMID: 11358682 [PubMed - indexed for MEDLINE]Related articles

    10.

    High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients.

    Cai W, He JC, Zhu L, Peppa M, Lu C, Uribarri J, Vlassara H.

    Circulation. 2004 Jul 20;110(3):285-91. Epub 2004 Jul 12.PMID: 15249511 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.

    Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, Ohtoshi K, Hayaishi-Okano R, Kosugi K, Hori M, Yamasaki Y.

    Diabetes Care. 2005 Nov;28(11):2716-21.PMID: 16249545 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Macronutrients, advanced glycation end products, and vascular reactivity.

    Dandona P, Chaudhuri A, Mohanty P.

    Diabetes Care. 2007 Oct;30(10):2750-1. No abstract available. PMID: 17901533 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells.

    Zhang J, Ren S, Shen GX.

    Atherosclerosis. 2000 Jun;150(2):299-308.PMID: 10856522 [PubMed - indexed for MEDLINE]Related articles

    14.

    Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

    Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF.

    Diabetes Care. 1999 Sep;22(9):1543-8.PMID: 10480523 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

    Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ.

    Diabetologia. 2006 Nov;49(11):2756-62. Epub 2006 Sep 13.PMID: 16969649 [PubMed - indexed for MEDLINE]Related articles

    16.

    Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.

    Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D.

    Diabetes Care. 2006 Sep;29(9):2064-71.PMID: 16936154 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits.

    Vlassara H, Fuh H, Donnelly T, Cybulsky M.

    Mol Med. 1995 May;1(4):447-56.PMID: 8521302 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension.

    Zieman SJ, Melenovsky V, Clattenburg L, Corretti MC, Capriotti A, Gerstenblith G, Kass DA.

    J Hypertens. 2007 Mar;25(3):577-83.PMID: 17278974 [PubMed - indexed for MEDLINE]Related articles

    19.

    Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans.

    Enomoto M, Adachi H, Yamagishi S, Takeuchi M, Furuki K, Hino A, Hiratsuka A, Takajo Y, Imaizumi T.

    Metabolism. 2006 Jul;55(7):912-7.PMID: 16784963 [PubMed - indexed for MEDLINE]Related articles

    20.

    Advanced glycation end products in nondiabetic patients with coronary artery disease.

    Kanauchi M, Tsujimoto N, Hashimoto T.

    Diabetes Care. 2001 Sep;24(9):1620-3.PMID: 11522709 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity